Global Mycoplasma Testing Market

Global Mycoplasma Testing Market Size, Share, and COVID-19 Impact Analysis, By Product (Instruments and Kits & Reagents), By Technology (PCR, ELISA, Direct Assay, and Microbial Culture), By Application (Cell Line Testing, Virus Testing, End of Production Cells Testing, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023-2033.

Release Date
Aug 2025
Report ID
DAR1476
Pages
240
Report Format

Global Mycoplasma Testing Market Overview

  • Global Mycoplasma Testing Market Size is Anticipated To Exceed USD 2,560.7 Million by 2033, Growing at a CAGR of 10.7% from 2023 to 2033.
  • The Market Growth is the raising awareness of the risks of contamination in cell culture research and biopharmaceutical manufacturing.
  • Strict requirements for testing have been enforced by regulatory bodies globally, particularly in the production of biologics, vaccines, and gene therapies.
  • Pharmaceutical businesses are developing improved medicines as a result of the rise in chronic diseases, which calls for high-quality, contamination-free products.
  • The demand for frequent mycoplasma testing has been further spurred by the growth of cell and gene therapy research as well as the increasing use of contract manufacturing organizations (CMOs) and research organizations (CROs).
  • The speed, accuracy, and scalability of testing have increased because of technological advancements including automation, real-time PCR, and NGS-based assays.

https://www.decisionsadvisors.com/assets/rd/global-mycoplasma-testing-market-size.png

Major vendors in the Global Mycoplasma Testing Market 

Thermo Fisher Scientific, Inc., Lonza Group AG, Merck KGaA, Charles River Laboratories International, Inc., PromoCell GmbH, American Type Culture Collection, Asahi Kasei Medical Co., Ltd, Sartorius AG, InvivoGen, Eurofins Scientific, (ATCC) American Type Culture Collection, and Others.

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Decision Advisors has segmented the mycoplasma testing market based on the below-mentioned segments:

Global Mycoplasma Testing Market

Global Mung-bean Paste Market, By Product 

  • Instruments
  • Kits & Reagents

Global Mycoplasma Testing Market , By Technology

  • PCR
  • ELISA
  • Direct Assay
  • Microbial Culture

Global Mycoplasma Testing Market , By Application

  • Cell Line Testing
  • Virus Testing
  • End of Production Cells Testing
  • Others

 

Global Mycoplasma Testing Market , By Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

 

Request Table of Contents:

Check Licence

Choose the plan that fits you best: Single User, Multi-User, or Enterprise solutions tailored for your needs.

Report Details

Pages 240 pages
Delivery PDF & Excel, via Email
Language English
Request Discount  

15% Free Customization

Share your requirements

Request Customization  

We Have You Covered

  • 24/7 Analyst Support
  • Clients Across the Globe
  • Tailored Insights
  • Technology Tracking
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Studies
  • Market Overview
  • Market Segmentation
  • Growth Drivers
  • Market Opportunities
  • Regulatory Insights
  • Innovation & Sustainability

Report Details

Pages 240
Delivery PDF & Excel via Email
Language English
Release Aug 2025
Access Download from this page
Request Sample